Distinct morning and evening fatigue profiles in gastrointestinal cancer during chemotherapy

Yufen Lin, Donald E. Bailey, Sharron L. Docherty, Laura S. Porter, Bruce Cooper, Steven Paul, Kord Kober, Marilyn J. Hammer, Fay Wright, Yvette Conley, Jon Levine, Christine Miaskowski

Research output: Contribution to journalArticlepeer-review

Abstract

Background Purposes were to identify subgroups of patients with gastrointestinal cancers with distinct morning and evening fatigue severity profiles and evaluate for differences among these subgroups in demographic and clinical characteristics, co-occurring symptoms and quality of life (QOL) outcomes. Methods Patients with gastrointestinal cancers (n=405) completed questionnaires six times over two cycles of chemotherapy. Latent profile analysis was used to identify distinct morning and evening fatigue profiles. Differences in demographic and clinical characteristics, co-occurring symptoms and QOL outcomes among the subgroups were evaluated using parametric and nonparametric tests. Results Two distinct mornings (ie, low and very high) and three distinct evenings (ie, low, moderate and very high) fatigue classes were identified. Common risk factors for both morning and evening fatigue included younger age, lower performance status, higher comorbidity burden and self-reported depression. Higher levels of morning fatigue were associated with being unmarried, living alone, being unemployed, having a lower income, lack of regular exercise and a self-reported diagnosis of anaemia. Higher levels of evening fatigue were associated with being women, white and having childcare responsibilities. Patients in the very high morning and evening fatigue classes reported higher levels of anxiety, depressive symptoms, sleep disturbance and pain and lower levels of attentional function and poorer QOL. Conclusion Findings provide new insights into risk factors for and deleterious effects of morning and evening fatigue in patients with gastrointestinal cancers. Clinicians can use this information to identify high-risk patients and develop individualised interventions for morning and evening fatigue and other co-occurring symptoms.

Original languageEnglish (US)
Pages (from-to)E373-E381
JournalBMJ Supportive and Palliative Care
Volume13
Issue numbere2
DOIs
StatePublished - May 28 2021

ASJC Scopus subject areas

  • Medical–Surgical
  • Oncology(nursing)
  • Medicine (miscellaneous)

Fingerprint

Dive into the research topics of 'Distinct morning and evening fatigue profiles in gastrointestinal cancer during chemotherapy'. Together they form a unique fingerprint.

Cite this